Estudo de toxicidade retiniana após injeções intravítreas seriadas de infliximabe em olhos de coelhos

Detalhes bibliográficos
Autor(a) principal: Rassi, Alan Ricardo
Data de Publicação: 2011
Outros Autores: Rigueiro, Moacyr Pezati [UNIFESP], Isaac, David Leonardo Cruvinel, Dourado, Letícia [UNIFESP], Abud, Murilo Batista, Freitas, Éricka Campos, Carneiro, Luciana Barbosa, Ávila, Marcos Pereira de
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1590/S0004-27492011000500009
http://repositorio.unifesp.br/handle/11600/6657
Resumo: PURPOSE: To determine retinal and choroid toxicity levels of two and three infliximab intravitreous injections in albino rabbits by means of electroretinographic, histological and ophthalmological clinical tests. METHODS: 12 albino rabbits were used in the study. Each eye was given two (n=10 eyes) or three (n=10 eyes) serial intravitreous 2 mg infliximab injections dissolved in 0.06 ml of saline, at monthly intervals. A separate group of rabbits (n=4 eyes) served as a control group. Ninety days after the study had begun, the rabbits underwent clinical and electroretinographic tests, and after being enucleated, the eyes were examined for histological changes. RESULTS: Slit-lamp biomicroscopy and fundoscopic examination did not reveal any significant retinal abnormalities in the eyes injected with infliximab and control eyes or in pre- and post-treated eyes. The histological change that was noted was the presence of rare lymphocytes and eosinophils in the posterior vitreous of some of the rabbits subjected to two or three injections, but it was not considered clinically significant. A severe inflammatory reaction with vitreous exudates and ganglion cell edema in a single rabbit was clinically significant. The electroretinographic tests showed amplitudes that were on the average 12-13% smaller than those obtained before the treatment, however, there were no statistically significant differences when comparing the amplitude or the implicit time between pre- and post-treatment electroretinographic findings. CONCLUSION: Two and three intravitreous 2 mg infliximab injections in rabbits at monthly intervals did not cause any changes after a 90-day follow-up, according to histological and electroretinographic tests and after clinical evaluation. Differently from prior studies that have investigated potential retinotoxicity effects after single administrations, this study investigated the possibility of retinotoxicity after multiple injections. Clinical studies in humans should be conducted to better evaluate the safety of this drug in the treatment of certain diseases affecting the retina and the choroid.
id UFSP_8fe0a4b909f57b1ad0e4d491fa279b2e
oai_identifier_str oai:repositorio.unifesp.br/:11600/6657
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Estudo de toxicidade retiniana após injeções intravítreas seriadas de infliximabe em olhos de coelhosA safety study of retinal toxicity after serial intravitreal injections of infliximab in rabbits eyesTumor necrosis factor-alphaInjections, intravenousRetinaRetinal diseasesChoroid diseasesMacular degenerationAntibodies, mono-clonalElectroretinographyAnimalsRabbitsFator de necrose tumoral alfaInjeções intravenosasRetinaDoenças retinianasDoenças da coróideDegeneração macularAnticorpos monoclonaisEletrorretinografiaAnimaisCoelhosPURPOSE: To determine retinal and choroid toxicity levels of two and three infliximab intravitreous injections in albino rabbits by means of electroretinographic, histological and ophthalmological clinical tests. METHODS: 12 albino rabbits were used in the study. Each eye was given two (n=10 eyes) or three (n=10 eyes) serial intravitreous 2 mg infliximab injections dissolved in 0.06 ml of saline, at monthly intervals. A separate group of rabbits (n=4 eyes) served as a control group. Ninety days after the study had begun, the rabbits underwent clinical and electroretinographic tests, and after being enucleated, the eyes were examined for histological changes. RESULTS: Slit-lamp biomicroscopy and fundoscopic examination did not reveal any significant retinal abnormalities in the eyes injected with infliximab and control eyes or in pre- and post-treated eyes. The histological change that was noted was the presence of rare lymphocytes and eosinophils in the posterior vitreous of some of the rabbits subjected to two or three injections, but it was not considered clinically significant. A severe inflammatory reaction with vitreous exudates and ganglion cell edema in a single rabbit was clinically significant. The electroretinographic tests showed amplitudes that were on the average 12-13% smaller than those obtained before the treatment, however, there were no statistically significant differences when comparing the amplitude or the implicit time between pre- and post-treatment electroretinographic findings. CONCLUSION: Two and three intravitreous 2 mg infliximab injections in rabbits at monthly intervals did not cause any changes after a 90-day follow-up, according to histological and electroretinographic tests and after clinical evaluation. Differently from prior studies that have investigated potential retinotoxicity effects after single administrations, this study investigated the possibility of retinotoxicity after multiple injections. Clinical studies in humans should be conducted to better evaluate the safety of this drug in the treatment of certain diseases affecting the retina and the choroid.OBJETIVO: Determinar os níveis de toxicidade de duas e três aplicações intravítreas de infliximabe na retina de coelhos albinos, por meio de exames clínicos oftalmológicos, eletrorretinográficos e histológicos. MÉTODOS: Foram utilizados doze coelhos albinos divididos em dois grupos. No primeiro grupo de 10 coelhos, cada olho recebeu duas (n=10 olhos) ou três injeções (n=10 olhos) intravítreas de 2 mg de infliximabe dissolvidos em 0,06 ml de solução salina, em intervalos mensais. Um segundo grupo de dois coelhos, que serviu como grupo controle (n=4 olhos), foram submetidos a duas e três aplicações intravítreas de BSS. Noventa dias após, os coelhos foram novamente submetidos a exame oftalmológico (biomicroscopia, oftalmoscopia e tonometria), eletrorretinográfico e, após enucleados, a exame histológico. RESULTADOS: O exame biomicroscópico e oftalmoscópico não revelou anormalidades retinianas nos olhos injetados com infliximabe e no grupo controle. Alteração histológica notada foi a presença de raros linfócitos e eosinófilos no vítreo posterior em quatro e em seis olhos submetidos a duas e três aplicações de infliximabe sem significado clínico. A única alteração clinicamente significante foi uma reação inflamatória severa com presença de exsudatos vítreos na interface vítreo retiniana e discreto edema de células ganglionares nos dois olhos de um único coelho, sem alterações no vítreo posterior. Os exames eletrorretinográficos mostraram amplitudes em média 12-13% menores daquelas obtidas antes do tratamento, contudo não houve nenhuma diferença estatisticamente significante quando comparamos as amplitudes e a latencia entre os achados electrorretinográficos pré e pós-tratamento. CONCLUSÃO: Duas e três aplicações intravítreas de infliximabe em olhos de coelhos em intervalos mensais, na dosagem de 2 mg, não provocam alterações significantes após um seguimento de noventa dias, quer no exame histológico, na eletrorretinografia e na avaliação clínica oftalmológica. Conclui-se que doses seriadas de infliximabe por via intravítrea é um procedimento seguro. Estudos clínicos em humanos devem ser realizados para melhor avaliação da segurança do seu uso no tratamento de determinadas doenças que acometem a retina e a coroide.Universidade Federal de Goiás Centro de Referência em Oftalmologia Ophthalmology DepartmentUniversidade Federal de São Paulo (UNIFESP) Pathology DepartmentUniversidade Federal de Goiás Centro de Referência em Oftalmologia Setor de Retina e VítreoUniversidade Federal de Goiás Centro de Referência em Oftalmologia Setor de EletrofisiologiaUNIFESP, Pathology DepartmentSciELOConselho Brasileiro de OftalmologiaUniversidade Federal de Goiás Centro de Referência em Oftalmologia Ophthalmology DepartmentUniversidade Federal de São Paulo (UNIFESP)Universidade Federal de Goiás Centro de Referência em Oftalmologia Setor de Retina e VítreoUniversidade Federal de Goiás Centro de Referência em Oftalmologia Setor de EletrofisiologiaRassi, Alan RicardoRigueiro, Moacyr Pezati [UNIFESP]Isaac, David Leonardo CruvinelDourado, Letícia [UNIFESP]Abud, Murilo BatistaFreitas, Éricka CamposCarneiro, Luciana BarbosaÁvila, Marcos Pereira de2015-06-14T13:43:18Z2015-06-14T13:43:18Z2011-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion352-356application/pdfhttp://dx.doi.org/10.1590/S0004-27492011000500009Arquivos Brasileiros de Oftalmologia. Conselho Brasileiro de Oftalmologia, v. 74, n. 5, p. 352-356, 2011.10.1590/S0004-27492011000500009S0004-27492011000500009.pdf0004-2749S0004-27492011000500009http://repositorio.unifesp.br/handle/11600/6657WOS:000298348100010porArquivos Brasileiros de Oftalmologiainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-28T23:14:31Zoai:repositorio.unifesp.br/:11600/6657Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-07-28T23:14:31Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Estudo de toxicidade retiniana após injeções intravítreas seriadas de infliximabe em olhos de coelhos
A safety study of retinal toxicity after serial intravitreal injections of infliximab in rabbits eyes
title Estudo de toxicidade retiniana após injeções intravítreas seriadas de infliximabe em olhos de coelhos
spellingShingle Estudo de toxicidade retiniana após injeções intravítreas seriadas de infliximabe em olhos de coelhos
Rassi, Alan Ricardo
Tumor necrosis factor-alpha
Injections, intravenous
Retina
Retinal diseases
Choroid diseases
Macular degeneration
Antibodies, mono-clonal
Electroretinography
Animals
Rabbits
Fator de necrose tumoral alfa
Injeções intravenosas
Retina
Doenças retinianas
Doenças da coróide
Degeneração macular
Anticorpos monoclonais
Eletrorretinografia
Animais
Coelhos
title_short Estudo de toxicidade retiniana após injeções intravítreas seriadas de infliximabe em olhos de coelhos
title_full Estudo de toxicidade retiniana após injeções intravítreas seriadas de infliximabe em olhos de coelhos
title_fullStr Estudo de toxicidade retiniana após injeções intravítreas seriadas de infliximabe em olhos de coelhos
title_full_unstemmed Estudo de toxicidade retiniana após injeções intravítreas seriadas de infliximabe em olhos de coelhos
title_sort Estudo de toxicidade retiniana após injeções intravítreas seriadas de infliximabe em olhos de coelhos
author Rassi, Alan Ricardo
author_facet Rassi, Alan Ricardo
Rigueiro, Moacyr Pezati [UNIFESP]
Isaac, David Leonardo Cruvinel
Dourado, Letícia [UNIFESP]
Abud, Murilo Batista
Freitas, Éricka Campos
Carneiro, Luciana Barbosa
Ávila, Marcos Pereira de
author_role author
author2 Rigueiro, Moacyr Pezati [UNIFESP]
Isaac, David Leonardo Cruvinel
Dourado, Letícia [UNIFESP]
Abud, Murilo Batista
Freitas, Éricka Campos
Carneiro, Luciana Barbosa
Ávila, Marcos Pereira de
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de Goiás Centro de Referência em Oftalmologia Ophthalmology Department
Universidade Federal de São Paulo (UNIFESP)
Universidade Federal de Goiás Centro de Referência em Oftalmologia Setor de Retina e Vítreo
Universidade Federal de Goiás Centro de Referência em Oftalmologia Setor de Eletrofisiologia
dc.contributor.author.fl_str_mv Rassi, Alan Ricardo
Rigueiro, Moacyr Pezati [UNIFESP]
Isaac, David Leonardo Cruvinel
Dourado, Letícia [UNIFESP]
Abud, Murilo Batista
Freitas, Éricka Campos
Carneiro, Luciana Barbosa
Ávila, Marcos Pereira de
dc.subject.por.fl_str_mv Tumor necrosis factor-alpha
Injections, intravenous
Retina
Retinal diseases
Choroid diseases
Macular degeneration
Antibodies, mono-clonal
Electroretinography
Animals
Rabbits
Fator de necrose tumoral alfa
Injeções intravenosas
Retina
Doenças retinianas
Doenças da coróide
Degeneração macular
Anticorpos monoclonais
Eletrorretinografia
Animais
Coelhos
topic Tumor necrosis factor-alpha
Injections, intravenous
Retina
Retinal diseases
Choroid diseases
Macular degeneration
Antibodies, mono-clonal
Electroretinography
Animals
Rabbits
Fator de necrose tumoral alfa
Injeções intravenosas
Retina
Doenças retinianas
Doenças da coróide
Degeneração macular
Anticorpos monoclonais
Eletrorretinografia
Animais
Coelhos
description PURPOSE: To determine retinal and choroid toxicity levels of two and three infliximab intravitreous injections in albino rabbits by means of electroretinographic, histological and ophthalmological clinical tests. METHODS: 12 albino rabbits were used in the study. Each eye was given two (n=10 eyes) or three (n=10 eyes) serial intravitreous 2 mg infliximab injections dissolved in 0.06 ml of saline, at monthly intervals. A separate group of rabbits (n=4 eyes) served as a control group. Ninety days after the study had begun, the rabbits underwent clinical and electroretinographic tests, and after being enucleated, the eyes were examined for histological changes. RESULTS: Slit-lamp biomicroscopy and fundoscopic examination did not reveal any significant retinal abnormalities in the eyes injected with infliximab and control eyes or in pre- and post-treated eyes. The histological change that was noted was the presence of rare lymphocytes and eosinophils in the posterior vitreous of some of the rabbits subjected to two or three injections, but it was not considered clinically significant. A severe inflammatory reaction with vitreous exudates and ganglion cell edema in a single rabbit was clinically significant. The electroretinographic tests showed amplitudes that were on the average 12-13% smaller than those obtained before the treatment, however, there were no statistically significant differences when comparing the amplitude or the implicit time between pre- and post-treatment electroretinographic findings. CONCLUSION: Two and three intravitreous 2 mg infliximab injections in rabbits at monthly intervals did not cause any changes after a 90-day follow-up, according to histological and electroretinographic tests and after clinical evaluation. Differently from prior studies that have investigated potential retinotoxicity effects after single administrations, this study investigated the possibility of retinotoxicity after multiple injections. Clinical studies in humans should be conducted to better evaluate the safety of this drug in the treatment of certain diseases affecting the retina and the choroid.
publishDate 2011
dc.date.none.fl_str_mv 2011-10-01
2015-06-14T13:43:18Z
2015-06-14T13:43:18Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/S0004-27492011000500009
Arquivos Brasileiros de Oftalmologia. Conselho Brasileiro de Oftalmologia, v. 74, n. 5, p. 352-356, 2011.
10.1590/S0004-27492011000500009
S0004-27492011000500009.pdf
0004-2749
S0004-27492011000500009
http://repositorio.unifesp.br/handle/11600/6657
WOS:000298348100010
url http://dx.doi.org/10.1590/S0004-27492011000500009
http://repositorio.unifesp.br/handle/11600/6657
identifier_str_mv Arquivos Brasileiros de Oftalmologia. Conselho Brasileiro de Oftalmologia, v. 74, n. 5, p. 352-356, 2011.
10.1590/S0004-27492011000500009
S0004-27492011000500009.pdf
0004-2749
S0004-27492011000500009
WOS:000298348100010
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv Arquivos Brasileiros de Oftalmologia
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 352-356
application/pdf
dc.publisher.none.fl_str_mv Conselho Brasileiro de Oftalmologia
publisher.none.fl_str_mv Conselho Brasileiro de Oftalmologia
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268282911326208